These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38104855)

  • 1. A meta-analysis of the medium- to long-term outcomes in patients with chronic deep venous disease treated with dedicated venous stents.
    Badesha AS; Black SA; Khan G; Harper AJ; Thulasidasan N; Doyle A; Khan T
    J Vasc Surg Venous Lymphat Disord; 2024 May; 12(3):101722. PubMed ID: 38104855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents.
    Badesha AS; Bains PRS; Bains BRS; Khan T
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):267-282.e4. PubMed ID: 33965610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review on the Incidence of Stent Migration in the Treatment of Acute and Chronic Iliofemoral Disease Using Dedicated Venous Stents.
    Badesha AS; Siddiqui MM; Bains BRS; Bains PRS; Khan T
    Ann Vasc Surg; 2022 Jul; 83():328-348. PubMed ID: 35051587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent.
    de Wolf MA; de Graaf R; Kurstjens RL; Penninx S; Jalaie H; Wittens CH
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):518-26. PubMed ID: 26187656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.
    Majeed GM; Lodhia K; Carter J; Kingdon J; Morris RI; Gwozdz A; Saratzis A; Saha P
    J Endovasc Ther; 2022 Jun; 29(3):478-492. PubMed ID: 34758673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
    Jayaraj A; Noel C; Kuykendall R; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of stent occlusion after iliocaval stenting.
    Jayaraj A; Crim W; Knight A; Raju S
    J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):56-64. PubMed ID: 30442577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of venous stents for iliac and venacaval occlusive disease.
    Williams ZF; Dillavou ED
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):145-153. PubMed ID: 31699668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary outcomes of elective iliocaval and infrainguinal venous intervention for post-thrombotic chronic venous occlusive disease.
    Rollo JC; Farley SM; Jimenez JC; Woo K; Lawrence PF; DeRubertis BG
    J Vasc Surg Venous Lymphat Disord; 2017 Nov; 5(6):789-799. PubMed ID: 29037346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between a dedicated venous stent and standard composite Wallstent-Z stent approach to iliofemoral venous stenting: Intermediate-term outcomes.
    Powell T; Raju S; Jayaraj A
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):82-90.e2. PubMed ID: 35872144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early thrombosis after iliac stenting for venous outflow occlusion is related to disease severity and type of anticoagulation.
    Marston WA; Browder SE; Iles K; Griffith A; McGinigle KL
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1399-1407.e1. PubMed ID: 33667740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected major role for venous stenting in deep reflux disease.
    Raju S; Darcey R; Neglén P
    J Vasc Surg; 2010 Feb; 51(2):401-8; discussion 408. PubMed ID: 20006920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions - long-term efficacy and safety results from the Arnsberg venous registry.
    Lichtenberg MKW; Stahlhoff WF; Stahlhoff S; Özkapi A; Breuckmann F; de Graaf R
    Vasa; 2021 Jan; 50(1):52-58. PubMed ID: 32697148
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
    Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
    J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the VENOVO™ and Sinus Obliquus™ venous stents in the treatment of non-thrombotic or post-thrombotic iliac vein lesions - Short-term results from a multi-centre Asian cohort.
    Tang TY; Lim MH; Damodharan K; Yap CJ; Lee SQ; Yap HY; Chong TT; Tan JW
    Phlebology; 2021 Feb; 36(1):70-78. PubMed ID: 32811290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-term outcomes after inferior vena cava reconstruction for acute and chronic deep vein thrombosis and retroperitoneal fibrosis.
    Thulasidasan N; Morris R; Theodoulou I; Breen K; Saha P; Karunanithy N; Black SA
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):607-616.e2. PubMed ID: 34508871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
    Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
    Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.